# Increased semaphorin, neuropilin, and plexin expression plays a role in recovery after traumatic brain injury

**Authors:** Aslı Okan, Zeynep Yılmaz Şükranlı, Taha Berkay Bor, Ali İmran Berkyürek, Serpil Taheri, Züleyha Doğanyiğit

PMC · DOI: 10.1007/s11011-026-01788-x · 2026-02-16

## TL;DR

This study explores how semaphorin, neuropilin, and plexin proteins are involved in recovery after traumatic brain injury, suggesting potential for new treatments.

## Contribution

The study reveals increased expression of semaphorin, neuropilin, and plexin proteins in recovery from traumatic brain injury.

## Key findings

- Males show increased Sem-3F, Plexin-A1, Neuropilin-1, and TNF-α protein expression in the hippocampus after chronic short-term mTBI.
- Chronic long-term mTBI increases neuropilin 1 gene expression in multiple brain regions.
- Semaphorin, neuropilin, and plexin proteins may aid in developing new treatment techniques for TBI recovery.

## Abstract

One of the leading causes of death and disability globally, affecting people of all ages, is traumatic brain injury (TBI). Damage to neural tissues associated with TBI can be classified into two categories: primary damage caused by direct mechanical forces resulting from trauma and secondary damage characterized by long-term neuroinflammation resulting from the molecular response of tissues and cells following primary injury. Although the effects of semaphorin (Sema) molecules on neural repair and regeneration are known, their role in the secondary injury process after TBI remains unclear. Sema proteins bind to their receptors, members of the neuropilin and plexin protein families, to carry out their actions. In this study, after mild TBI (mTBI) was induced, an acute mTBI group (observed for 24 h), a short-term mTBI chronic group, a long-term mTBI chronic group, and a sham group were created. As a result, neuronal damage is increased in acute and chronic mTBI models. Males exhibit increased levels of Sem-3 F, Plexin-A1, Neuropilin-1, and TNF-α protein expression in the hippocampus, particularly following chronic short-term mTBI. In addition, the chronic long-term group presented greater neuropilin 1 gene expression in the hypothalamus, hippocampus, pituitary, and hypophysis. Our findings suggest that semaphorin, neuropilin, and plexin proteins may help create new treatment techniques on the basis of their potential involvement in establishing and recovering from primary and secondary damage following TBI.

Males exhibit increased levels of Sem-3F, Plexin-A1, Neuropilin-1, and TNF-α protein expression in the hippocampus, particularly following chronic short-term mTBI. In addition, the chronic long-term group presented greater neuropilin 1 gene expression in the hypothalamus, hippocampus, pituitary, and hypophysis. Our findings suggest that semaphorin, neuropilin, and plexin proteins may contribute to the development of new treatment techniques based on their potential role in establishing and recovering from primary and secondary damage following traumatic brain injury.

The online version contains supplementary material available at 10.1007/s11011-026-01788-x.

## Linked entities

- **Genes:** LOC129354602 (semaphorin-3F-like) [NCBI Gene 129354602], PLXNA1 (plexin A1) [NCBI Gene 5361], NRP1 (neuropilin 1) [NCBI Gene 395560], NRP1 (neuropilin 1) [NCBI Gene 395560]
- **Proteins:** LOC129354602 (semaphorin-3F-like), PLXNA1 (plexin A1), NRP1 (neuropilin 1), TNF (tumor necrosis factor)
- **Diseases:** traumatic brain injury (MONDO:0858950)

## Full-text entities

- **Genes:** SEMA3B (semaphorin 3B) [NCBI Gene 7869] {aka LUCA-1, SEMA5, SEMAA, SemA, semaV}, Plxna1 (plexin A1) [NCBI Gene 18844] {aka 2600013D04Rik, NOV, PlexA1, Plxn1, mKIAA4053}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, SEMA3A (semaphorin 3A) [NCBI Gene 10371] {aka COLL1, HH16, Hsema-I, Hsema-III, SEMA1, SEMAD}, PLXNA1 (plexin A1) [NCBI Gene 5361] {aka DWOPNED, NOV, NOVP, PLEXIN-A1, PLXN1}, Sema3b (sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B) [NCBI Gene 20347] {aka SemA, Semaa, sema5, semaV}, SEMA3F (semaphorin 3F) [NCBI Gene 6405] {aka SEMA-IV, SEMA4, SEMAK}, Nptn (neuroplastin) [NCBI Gene 20320] {aka NP65, SDR-1, Sdfr1}, Sema3a (sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A) [NCBI Gene 20346] {aka Hsema-I, SEMA1, SemD, Semad, coll-1}, Nrp1 (neuropilin 1) [NCBI Gene 18186] {aka C530029I03, NP-1, NPN-1, Npn1, Nrp}, Plxna4 (plexin A4) [NCBI Gene 243743] {aka 9330117B14, Plxa4, mKIAA1550}, Nepn (nephrocan) [NCBI Gene 66650] {aka 5730521E12Rik, Npn, periolin}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, NRP1 (neuropilin 1) [NCBI Gene 8829] {aka BDCA4, CD304, NP1, NRP, VEGF165R}, Sema3f (sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F) [NCBI Gene 20350] {aka Sema4, Semak}, NRP2 (neuropilin 2) [NCBI Gene 8828] {aka NP2, NPN2, PRO2714, VEGF165R2}
- **Diseases:** death (MESH:D003643), demyelinated lesions (MESH:D003711), CNS trauma (MESH:D020196), hippocampal damage (MESH:D000092223), epilepsy (MESH:D004827), mTBI (MESH:D001924), dementia (MESH:D003704), Neuronal damage (MESH:D009410), axonal damage (MESH:D001480), necrotic (MESH:D009336), myelin damage (MESH:D020279), MS (MESH:D009103), mitochondrial dysfunction (MESH:D028361), head trauma (MESH:D006259), inflammatory (MESH:D007249), neurodegeneration (MESH:D019636), injury (MESH:D014947), atrophy (MESH:D001284), neuroinflammation (MESH:D000090862), autism (MESH:D001321), TBI (MESH:D000070642), Alzheimer's disease (MESH:D000544), stroke (MESH:D020521), neurological diseases (MESH:D020271), neurological disorders (MESH:D009461)
- **Chemicals:** hematoxylin (MESH:D006416), H&amp;E (MESH:D006371), hydrogen peroxide (MESH:D006861), Gill III Hematoxylin (-), lipid (MESH:D008055), citrate (MESH:D019343), formaldehyde (MESH:D005557), alcohol (MESH:D000438), PBS (MESH:D007854), Eosin Y (MESH:D004801), methanol (MESH:D000432), paraffin (MESH:D010232), Entellan (MESH:C052885), xylol (MESH:D014992), biotin (MESH:D001710)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090], Meleagris gallopavo (common turkey, species) [taxon 9103]
- **Cell lines:** /c — Mus musculus (Mouse), Hepatocellular carcinoma of the mouse, Cancer cell line (CVCL_9103)

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12909346/full.md

---
Source: https://tomesphere.com/paper/PMC12909346